Oncology Institute, Inc., listed under ticker DFPH, is a healthcare-sector SPAC that came to market in 2021 targeting the oncology and value-based cancer care space. The company filed an amended quarterly report, Form 10-Q/A, with the Securities and Exchange Commission on December 14, 2021, bearing accession number 0001104659-21-149306. The amendment reflects updated disclosures during the active phase of the SPAC's business combination process in the oncology services industry. DFPH represents one of several healthcare-focused blank-check vehicles that pursued targets in the oncology vertical during the 2021 SPAC boom. For complete sponsor details, deal timelines, filing history, and live status data on DFPH and thousands of other SPACs, sign up for full access at SpacDesk.